Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by García Rodríguez, L. A.
Right arrow Articles by Hernández-Díaz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García Rodríguez, L. A.
Right arrow Articles by Hernández-Díaz, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2004; 159:23-31.
Copyright © 2004 by the Johns Hopkins Bloomberg School of Public Health


ORIGINAL CONTRIBUTIONS

Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

Luis Alberto García Rodríguez1  and Sonia Hernández-Díaz2

1 Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain.
2 Slone Epidemiology Center, Boston University, Boston, MA.

The association between nonsteroidal antiinflammatory drugs (NSAIDs) and upper gastrointestinal complications is well documented. However, epidemiologic data on the risk of clinically symptomatic but uncomplicated peptic ulcer are quite limited. The authors studied the association between prescription NSAIDs and the risk of symptomatic ulcer in a population-based cohort of 458,840 persons and 1,167,469 person-years in the United Kingdom between 1995 and 1999 and conducted a nested case-control analysis of 1,197 cases and 10,000 controls. The relative risk and 95% confidence intervals were estimated and adjusted for several factors known to be associated with gastrointestinal damage. The incidence rate of symptomatic ulcer was 1.03 (95% confidence interval (CI): 0.97, 1.08) cases per 1,000 person-years. Compared with nonusers, the relative risk was 2.9 (95% CI: 2.3, 3.6) for aspirin and 4.0 (95% CI: 3.2, 5.1) for nonaspirin NSAID users. For aspirin users, the relative risk was similar for doses up to 300 mg daily and for both gastric and duodenal ulcers. For nonaspirin NSAIDs, the relative risk was 2.6 (95% CI: 2.0, 3.5) for medium daily doses or lower and 4.9 (95% CI: 3.8, 6.5) for high daily doses; it was 5.6 (95% CI: 3.9, 8.2) for gastric and 3.1 (95% CI: 2.3, 4.2) for duodenal ulcers. The risk of symptomatic ulcer for aspirin and nonaspirin NSAIDs was elevated throughout treatment. These findings suggest that NSAIDs might not only complicate but also originate clinically relevant peptic ulcers.

anti-inflammatory agents, non-steroidal; aspirin; drug toxicity; peptic ulcer

Abbreviations: Abbreviations: CI, confidence interval; GPRD, General Practice Research Database; ICD, International Classification of Diseases, Eighth Revision; NSAID, nonsteroidal antiinflammatory drug; RR, relative risk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
D H Solomon, N J Goodson, J N Katz, M E Weinblatt, J Avorn, S Setoguchi, C Canning, and S Schneeweiss
Patterns of cardiovascular risk in rheumatoid arthritis
Ann Rheum Dis, December 1, 2006; 65(12): 1608 - 1612.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
E. Munsterhjelm, T. T. Niemi, O. Ylikorkala, P. J. Neuvonen, and P. H. Rosenberg
Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers
Br. J. Anaesth., August 1, 2006; 97(2): 226 - 231.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.